{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:02:38Z","timestamp":1793833358179,"version":"4.6.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China, China","doi-asserted-by":"publisher","award":["81171209"],"award-info":[{"award-number":["81171209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China, China","doi-asserted-by":"publisher","award":["81371406"],"award-info":[{"award-number":["81371406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China, China","doi-asserted-by":"publisher","award":["81471309"],"award-info":[{"award-number":["81471309"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Qingdao Key Health Discipline Development Fund"},{"name":"Qingdao Outstanding Health Professional Development Fund"}],"content-domain":{"domain":["clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.neurobiolaging.2014.10.042","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T09:35:14Z","timestamp":1417599314000},"page":"1505-1518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["The link between the SNCA gene and parkinsonism"],"prefix":"10.1016","volume":"36","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2013.11.033","article-title":"Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease","volume":"337","author":"Ai","year":"2014","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib2","doi-asserted-by":"crossref","first-page":"e7114","DOI":"10.1371\/journal.pone.0007114","article-title":"Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy","volume":"4","author":"Al-Chalabi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib4","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1093\/hmg\/dds309","article-title":"Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic","volume":"21","author":"Arduino","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/cib.3.2.10964","article-title":"The regulation of synaptic function by alpha-synuclein","volume":"3","author":"Bellani","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature05915","article-title":"The complex language of chromatin regulation during transcription","volume":"447","author":"Berger","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2013.09.010","article-title":"The prevalence and genetics of Parkinson's disease in sub-Saharan Africans","volume":"335","author":"Blanckenberg","year":"2013","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12031-012-9820-7","article-title":"Age at onset in LRRK2-associated PD is modified by SNCA variants","volume":"48","author":"Botta-Orfila","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/ene.12315","article-title":"Genetic assessment of familial and early-onset Parkinson's disease in a Greek population","volume":"21","author":"Bozi","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/mds.25469","article-title":"SNCA: major genetic modifier of age at onset of Parkinson's disease","volume":"28","author":"Brockmann","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.04.005","article-title":"Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease","volume":"306","author":"Burbulla","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib14","doi-asserted-by":"crossref","first-page":"15227","DOI":"10.1523\/JNEUROSCI.3545-12.2012","article-title":"Systematic mutagenesis of alpha-synuclein reveals distinct sequence requirements for physiological and pathological activities","volume":"32","author":"Burre","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in\u00a0vivo and in\u00a0vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1326-6-83","article-title":"Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons","volume":"6","author":"Cabeza-Arvelaiz","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2012.11.007","article-title":"Expression of human E46K-mutated alpha-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment","volume":"240","author":"Cannon","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12031-011-9669-1","article-title":"A\u00a0search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease","volume":"47","author":"Cardo","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2014.01.009","article-title":"Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165\/rs11931074 polymorphisms","volume":"562","author":"Cardo","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10048-008-0138-0","article-title":"Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease","volume":"9","author":"Choi","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuro.2011.05.012","article-title":"Neuroprotection of alpha-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K","volume":"32","author":"Choong","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib23","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","article-title":"Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy","volume":"286","author":"Choubey","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.parkreldis.2013.02.008","article-title":"Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions","volume":"19","author":"Chung","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mds.23376","article-title":"Common variants in PARK loci and related genes and Parkinson's disease","volume":"26","author":"Chung","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/mds.25841","article-title":"Alpha-synuclein repeat variants and survival in Parkinson's disease","volume":"29","author":"Chung","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","article-title":"The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease","volume":"21","author":"Clayton","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib28","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1111\/febs.12471","article-title":"alpha-Synuclein as an intrinsically disordered monomer\u2013fact or artefact?","volume":"280","author":"Coelho-Cerqueira","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib29","doi-asserted-by":"crossref","first-page":"a009423","DOI":"10.1101\/cshperspect.a009423","article-title":"Disruption of protein quality control in Parkinson's disease","volume":"2","author":"Cook","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib30","doi-asserted-by":"crossref","first-page":"489830","DOI":"10.1100\/2012\/489830","article-title":"Genetics and epigenetics of Parkinson's disease","volume":"2012","author":"Coppede","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/cn400041j","article-title":"Structures and free energy landscapes of the A53T mutant-type alpha-synuclein protein and impact of A53T mutation on the structures of the wild-type alpha-synuclein protein with dynamics","volume":"4","author":"Coskuner","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib32","doi-asserted-by":"crossref","first-page":"e9313","DOI":"10.1371\/journal.pone.0009313","article-title":"Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy","volume":"5","author":"Crews","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12017-011-8163-9","article-title":"Next-generation sequencing reveals regional differences of the alpha-synuclein methylation state independent of Lewy body disease","volume":"13","author":"de Boni","year":"2011","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib35","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","article-title":"Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases","volume":"286","author":"Desplats","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib36","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib37","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/mds.23948","article-title":"Parkinson's disease and alpha-synuclein expression","volume":"26","author":"Devine","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib38","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1021\/bi4002369","article-title":"alpha-Synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers","volume":"52","author":"DeWitt","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib39","doi-asserted-by":"crossref","first-page":"e00592","DOI":"10.7554\/eLife.00592","article-title":"Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2","volume":"2","author":"Diao","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib40","doi-asserted-by":"crossref","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","article-title":"Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153","volume":"285","author":"Doxakis","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12640-009-9094-1","article-title":"Reciprocal effects of alpha-synuclein overexpression and proteasome inhibition in neuronal cells and tissue","volume":"17","author":"Dyllick-Brenzinger","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson's disease: curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00109-013-1038-9","article-title":"Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology","volume":"91","author":"Eisbach","year":"2013","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib44","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.25005","article-title":"Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease","volume":"27","author":"Elliott","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib45","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","article-title":"alpha-Synuclein gene haplotypes are associated with Parkinson's disease","volume":"10","author":"Farrer","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib46","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","article-title":"alpha-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer","volume":"287","author":"Fauvet","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib47","first-page":"266","article-title":"Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations","volume":"2","author":"Fujishiro","year":"2013","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/archneurol.2011.802","article-title":"Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism","volume":"69","author":"Garraux","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.22499","article-title":"Head injury, alpha-synuclein Rep1, and Parkinson's disease","volume":"71","author":"Goldman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib50","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1074\/jbc.C113.538249","article-title":"Evidence of native alpha-synuclein conformers in the human brain","volume":"289","author":"Gould","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib51","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.neurobiolaging.2012.02.001","article-title":"Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1","volume":"33","author":"Gui","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib52","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1021\/ja310518p","article-title":"The dynamic structure of alpha-synuclein multimers","volume":"135","author":"Gurry","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib55","doi-asserted-by":"crossref","first-page":"266.e5","DOI":"10.1016\/j.neurobiolaging.2013.07.013","article-title":"The protective effect of LRRK2\u00a0p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants","volume":"35","author":"Heckman","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1212\/WNL.50.2.318","article-title":"Parkinsonism: onset, progression, and mortality","volume":"50","author":"Hoehn","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.febslet.2011.01.009","article-title":"The role of the C-terminus of human alpha-synuclein: intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers","volume":"585","author":"Hong","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","article-title":"The genetics and neuropathology of Parkinson's disease","volume":"124","author":"Houlden","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib59","first-page":"497","article-title":"Variant in the 3' region of SNCA associated with Parkinson's disease and serum alpha-synuclein levels","volume":"259","author":"Hu","year":"2012","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib60","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/mds.25243","article-title":"A\u00a0case of alpha-synuclein gene duplication presenting with head-shaking movements","volume":"28","author":"Itokawa","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib62","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1369-1600.2012.00495.x","article-title":"Reduced expression of alpha-synuclein in alcoholic brain: influence of SNCA-Rep1 genotype","volume":"19","author":"Janeczek","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib63","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1523\/JNEUROSCI.5634-10.2011","article-title":"alpha-Synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity","volume":"31","author":"Jin","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib64","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib65","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.0906277106","article-title":"Repression of alpha-synuclein expression and toxicity by microRNA-7","volume":"106","author":"Junn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.23746","article-title":"alpha-Synuclein oligomers and clinical implications for Parkinson disease","volume":"73","author":"Kalia","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib67","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.25499","article-title":"The many faces of alpha-synuclein mutations","volume":"28","author":"Kasten","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1601-183X.2007.00315.x","article-title":"Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning","volume":"7","author":"Keri","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2014.01.010","article-title":"Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: positive and negative effects","volume":"1550","author":"Khodr","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib70","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/dneu.20989","article-title":"Inclusion of a portion of the native SNCA 3'UTR reduces toxicity of human S129A SNCA on striatal-projecting dopamine neurons in rat substantia nigra","volume":"72","author":"Khodr","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib71","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainres.2011.04.036","article-title":"An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons","volume":"1395","author":"Khodr","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib72","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12031-012-9732-6","article-title":"Increased expression of alpha-synuclein by SNCA duplication is associated with resistance to toxic stimuli","volume":"47","author":"Kim","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib74","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/mds.25505","article-title":"A\u00a0mir-153 binding site variation in SNCA in a patient with Parkinson's disease","volume":"28","author":"Kim","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2011.07.003","article-title":"Age and alpha-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt\/PKB signaling","volume":"44","author":"Kim","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib76","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12272-011-0518-0","article-title":"Interference of alpha-synuclein with cAMP\/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells","volume":"34","author":"Kim","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00702-011-0717-3","article-title":"A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP","volume":"119","author":"Kurz","year":"2012","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib79","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbrc.2011.07.028","article-title":"Human alpha-synuclein modulates vesicle trafficking through its interaction with prenylated Rab acceptor protein 1","volume":"412","author":"Lee","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib80","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1074\/jbc.M111.306902","article-title":"Mutant protein A30P alpha-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics","volume":"287","author":"Lemkau","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib81","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib82","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ajmg.b.32143","article-title":"SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese","volume":"162B","author":"Li","year":"2013","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib83","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1523\/JNEUROSCI.0618-11.2011","article-title":"alpha-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies","volume":"31","author":"Lim","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib84","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","article-title":"Conditional expression of Parkinson's disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1","volume":"32","author":"Lin","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib85","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.nbd.2012.03.017","article-title":"Regional deficiencies in chaperone-mediated autophagy underlie alpha-synuclein aggregation and neurodegeneration","volume":"46","author":"Malkus","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib86","doi-asserted-by":"crossref","first-page":"a008870","DOI":"10.1101\/cshperspect.a008870","article-title":"Clinical approach to Parkinson's disease: features, diagnosis, and principles of management","volume":"2","author":"Massano","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib87","doi-asserted-by":"crossref","first-page":"e15522","DOI":"10.1371\/journal.pone.0015522","article-title":"CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease","volume":"5","author":"Matsumoto","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib88","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mcn.2011.11.006","article-title":"Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression","volume":"49","author":"McLean","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib89","doi-asserted-by":"crossref","first-page":"629.e5","DOI":"10.1016\/j.neurobiolaging.2011.10.014","article-title":"DLB and PDD: a role for mutations in dementia and Parkinson disease genes?","volume":"33","author":"Meeus","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neulet.2005.02.030","article-title":"Skin and platelet\u00a0alpha-synuclein as peripheral biomarkers of Parkinson's disease","volume":"381","author":"Michell","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib91","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00702-012-0784-0","article-title":"alpha-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system","volume":"119","author":"Mollenhauer","year":"2012","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib92","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","article-title":"MicroRNAs in Parkinson's disease","volume":"46","author":"Mouradian","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib93","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12035-013-8394-x","article-title":"alpha-Synuclein and mitochondrial dysfunction in Parkinson's disease","volume":"47","author":"Mullin","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib94","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-012-9352-5","article-title":"alpha-Synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK signalling pathway","volume":"23","author":"Musgrove","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib95","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0404.2008.01019.x","article-title":"Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population","volume":"118","author":"Myhre","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib96","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/mds.22682","article-title":"Expanding the clinical phenotype of SNCA duplication carriers","volume":"24","author":"Nishioka","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib97","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1074\/jbc.M401076200","article-title":"Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study","volume":"279","author":"Nuscher","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib98","doi-asserted-by":"crossref","first-page":"e60378","DOI":"10.1371\/journal.pone.0060378","article-title":"Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function","volume":"8","author":"Oaks","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib99","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12035-012-8369-3","article-title":"The central theme of Parkinson's disease: alpha-synuclein","volume":"47","author":"Ozansoy","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jnc.12131","article-title":"Activity-dependent secretion of alpha-synuclein by enteric neurons","volume":"125","author":"Paillusson","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib101","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.parkreldis.2006.12.006","article-title":"Association of alpha-synuclein gene haplotypes with Parkinson's disease","volume":"13","author":"Parsian","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2014.10.042_bib102","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S1353-8020(11)70021-9","article-title":"Genetic variants in sporadic Parkinson's disease: east vs west","volume":"18","author":"Peeraully","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib103","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10048-011-0292-7","article-title":"Genetic variability in SNCA and Parkinson's disease","volume":"12","author":"Pihlstrom","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib104","doi-asserted-by":"crossref","first-page":"e36397","DOI":"10.1371\/journal.pone.0036397","article-title":"Striatal dopamine transmission is subtly modified in human A53Talpha-synuclein overexpressing mice","volume":"7","author":"Platt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib105","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.bbagen.2014.02.013","article-title":"Number and brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells","volume":"1840","author":"Plotegher","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib106","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib107","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib108","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","article-title":"Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations","volume":"19","author":"Puschmann","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib109","doi-asserted-by":"crossref","first-page":"e36199","DOI":"10.1371\/journal.pone.0036199","article-title":"alpha-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease","volume":"7","author":"Ritz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.21786","article-title":"Reply to: SNCA variants are associated with increased risk of multiple system atrophy","volume":"67","author":"Ross","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib111","doi-asserted-by":"crossref","first-page":"e63557","DOI":"10.1371\/journal.pone.0063557","article-title":"Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human alpha-synuclein","volume":"8","author":"Sarafian","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib112","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib113","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/ejhg.2012.84","article-title":"Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression","volume":"20","author":"Schmitt","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib114","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","article-title":"SNCA variants are associated with increased risk for multiple system atrophy","volume":"65","author":"Scholz","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.21966","article-title":"First appraisal of brain pathology owing to A30P mutant alpha-synuclein","volume":"67","author":"Seidel","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib116","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000355516","article-title":"Defining the native state of alpha-synuclein","volume":"13","author":"Selkoe","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib117","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e318264e353","article-title":"Large-scale replication and heterogeneity in Parkinson disease genetic loci","volume":"79","author":"Sharma","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib118","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamaneurol.2013.6222","article-title":"Association of Parkinson disease risk loci with mild parkinsonian signs in older persons","volume":"71","author":"Shulman","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib119","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4161\/auto.26751","article-title":"HMGB1 is involved in autophagy inhibition caused by SNCA\/alpha-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B","volume":"10","author":"Song","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib121","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib122","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","article-title":"Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease","volume":"246","author":"St Laurent","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib123","doi-asserted-by":"crossref","first-page":"1924.e5","DOI":"10.1016\/j.neurobiolaging.2011.04.001","article-title":"Genetic players in multiple system atrophy: unfolding the nature of the beast","volume":"32","author":"Stemberger","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib124","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000341997","article-title":"Delay discounting of reward and caudate nucleus volume in individuals with alpha-synuclein gene duplication before and after the development of Parkinson's disease","volume":"11","author":"Szamosi","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib125","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neurobiolaging.2013.11.019","article-title":"Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy","volume":"35","author":"Tan","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib126","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0304-3940(02)01178-3","article-title":"Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability","volume":"336","author":"Tan","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib127","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.parkreldis.2013.12.002","article-title":"Methylation of alpha-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients","volume":"20","author":"Tan","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2013.10.005","article-title":"Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P alpha-synuclein BAC transgenic mouse","volume":"62","author":"Taylor","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.parkreldis.2013.11.008","article-title":"Clinical and neuroimaging features of patient with early-onset Parkinson's disease with dementia carrying SNCA p.G51D mutation","volume":"20","author":"Tokutake","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib130","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2011.05.002","article-title":"Mechanisms underlying altered striatal synaptic plasticity in old A53T-alpha synuclein overexpressing mice","volume":"33","author":"Tozzi","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5607\/en.2012.21.3.123","article-title":"Environmental-genetic interactions in the pathogenesis of Parkinson's disease","volume":"21","author":"Tsuboi","year":"2012","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib132","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/ddq469","article-title":"Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21","volume":"20","author":"UK Parkinson's Disease Consortium","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib133","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2009.01.055","article-title":"Imaging the impact of genes on Parkinson's disease","volume":"164","author":"van der Vegt","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib134","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.parkreldis.2012.02.012","article-title":"The SNCA (A53T, A30P, E46K) and LRRK2 (G2019S) mutations are rare cause of Parkinson's disease in South Indian patients","volume":"18","author":"Vishwanathan Padmaja","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib135","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0b013e3182a9f449","article-title":"alpha-Synuclein in cutaneous autonomic nerves","volume":"81","author":"Wang","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib136","doi-asserted-by":"crossref","first-page":"17797","DOI":"10.1073\/pnas.1113260108","article-title":"A\u00a0soluble alpha-synuclein construct forms a dynamic tetramer","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib137","doi-asserted-by":"crossref","first-page":"e89353","DOI":"10.1371\/journal.pone.0089353","article-title":"Using gastrocnemius sEMG and plasma alpha-synuclein for the prediction of freezing of gait in Parkinson's disease patients","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib138","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jnnp-2011-301413","article-title":"An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology","volume":"83","author":"Wider","year":"2012","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib139","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J.\u00a0Cel. Biol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4161\/auto.7.4.14393","article-title":"The Parkinson disease protein alpha-synuclein inhibits autophagy","volume":"7","author":"Winslow","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib141","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12035-012-8325-2","article-title":"Molecular chaperones, alpha-synuclein, and neurodegeneration","volume":"47","author":"Witt","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib142","first-page":"315","article-title":"miRNAs and their putative roles in the development and progression of Parkinson's disease","volume":"3","author":"Wong","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib143","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.parkreldis.2012.02.018","article-title":"Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease","volume":"18","author":"Yonova-Doing","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib144","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2353\/ajpath.2009.080928","article-title":"Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein","volume":"175","author":"Yu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib145","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.21889","article-title":"SNCA variants and multiple system atrophy","volume":"67","author":"Yun","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.042_bib146","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014007088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014007088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T15:27:01Z","timestamp":1717601221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014007088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0197458014007088"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.042","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The link between the SNCA gene and parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}